Clinical Trial Update: CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing CBDV to placebo in individuals with Prader-Willi Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• CBDV (cannabidivarin)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Prader-Willi Syndrome | Phase 2 | Status: COMPLETED